Cargando…
Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity
Obesity is currently a major epidemic in the developed world. However, we lack a wide range of effective pharmacological treatments and therapies against obesity, and those approved are not devoid of adverse effects. Dietary components such as palmitoleic acid have been proposed to improve metabolic...
Autores principales: | Tovar, Rubén, Gavito, Ana Luisa, Vargas, Antonio, Soverchia, Laura, Hernandez-Folgado, Laura, Jagerovic, Nadine, Baixeras, Elena, Ciccocioppo, Roberto, Rodríguez de Fonseca, Fernando, Decara, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400335/ https://www.ncbi.nlm.nih.gov/pubmed/34444748 http://dx.doi.org/10.3390/nu13082589 |
Ejemplares similares
-
Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity
por: Tovar, Rubén, et al.
Publicado: (2023) -
Benzyl-1,2,4-triazoles as CB(1) Cannabinoid Receptor Ligands: Preparation and In Vitro Pharmacological Evaluation
por: Hernandez-Folgado, Laura, et al.
Publicado: (2016) -
The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats
por: Decara, Juan, et al.
Publicado: (2018) -
Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice
por: Gavito, Ana Luisa, et al.
Publicado: (2016) -
Allosteric Modulators of the CB(1) Cannabinoid Receptor: A Structural Update Review
por: Morales, Paula, et al.
Publicado: (2016)